In today’s recent session, 0.85 million shares of the Biohaven Ltd (NYSE:BHVN) have been traded, and its beta is 3.93. Most recently the company’s share price was $40.32, and it changed around $2.07 or 5.41% from the last close, which brings the market valuation of the company to $4.08B. BHVN at last check was trading at a discount to its 52-week high of $62.21, offering almost -54.29% off that amount. The share price’s 52-week low was $26.80, which indicates that the recent value has risen by an impressive 33.53% since then. We note from Biohaven Ltd’s average daily trading volume that its 10-day average is 0.64 million shares, with the 3-month average coming to 955.57K.
Biohaven Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.14. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended BHVN as a Hold, whereas 11 deemed it a Buy, and 0 rated it as Underweight. Biohaven Ltd is expected to report earnings per share of -1.47 for the current quarter.
Biohaven Ltd (NYSE:BHVN) trade information
Instantly BHVN has been showing a green trend so far today with a performance of 5.41% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 42.25 on recent trading dayincreased the stock’s daily price by 4.57%. The company’s shares are currently up 7.95% year-to-date, but still up 2.57% over the last five days. On the other hand, Biohaven Ltd (NYSE:BHVN) is 9.80% up in the 30-day period. We can see from the shorts that 9.94 million shares have been sold at a short interest cover period of 8.02 day(s).
The consensus price target as assigned by Wall Street analysts is $59.5, which translates to bulls needing to increase their stock price by 32.24% from its current value. Analyst projections state that BHVN is forecast to be at a low of $55 and a high of $65.
Biohaven Ltd (BHVN) estimates and forecasts
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of 9.09M in revenue for the current quarter. 5 analysts expect Biohaven Ltd to make 2.5M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 0.00%. Biohaven Ltd earnings are expected to increase by -56.61% in 2025, but the outlook is positive 1.06% per year for the next five years.
Biohaven Ltd (NYSE:BHVN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 11.20% of Biohaven Ltd shares, and 88.35% of them are in the hands of institutional investors. The stock currently has a share float of 99.49%. Biohaven Ltd stock is held by 348.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 8.9114% of the shares, which is about 7.27 million shares worth $252.41 million.
STIFEL FINANCIAL CORP, with 7.9417% or 6.48 million shares worth $224.94 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Sep 30, 2024 . The former held 2.43 shares worth $97.89 million, making up 2.40% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 2.11 shares worth around $84.77 million, which represents about 2.08% of the total shares outstanding.
